REFERENCES

• Profile of older Americans: 2000. Washington, DC: Administration on Aging. June 2001. wvwv.aoa.dhhs.gov/aoa/stats/profile/. Accessed August 6, 2001.
   Google Scholar
• Population ageing - a public health challenge. Fact Sheet No 135. Geneva, Switzerland: World Health Organization. September 1998. www.who.int /inf-fs/en/fact135.html. Accessed August 6, 2001.
   Google Scholar
• Aging into the 21st century: demographic changes. Washington, DC: Administration on Aging. May 1996. www.aoa.dhhs.gov/aoa/stats/aging21/demography.html. Accessed August 6, 2001.
   Google Scholar
• InfoNation. United Nations, www.un.org/. Accessed 30 October 2001.
   Google Scholar
• SchoenC.StrumpfE.DavisK.OsbornR.DonelanK.BlendonRJ.The Elderly's Experiences with Health Care in Five Nations. New York, NY: The Commonwealth Fund. May 2000. www.cmwf.org/programs/international/schoen_5nat_387.asp. Accessed August 6, 2001.
   Google Scholar
• WalopW.AmosS.DalzielW.et al.Prescription and nonprescription drug use among at-risk community-dwelling seniors in Ottawa-Carleton.Can J Clin Pharmacol.199969310010519735
   PubMedGoogle Scholar
• ThomasHF.SweetnamPM.JanchaweeB.LuscombeDK.Polypharmacy among older men in South Wales.Eur J Clin Pharmacol.19995541141510456493
   PubMed Web of Science ®Google Scholar
• Families USA. cost overdose: growth in drug spending for the elderly, 19922010. Washington, DC: Families USA Foundation. July 2000. Publication 00107. www.familiesusa.org/media/pdf/drugod.pdf. Accessed August 6, 2001.
   Google Scholar
• SprouleBA.BustoUE.BuckleC.HerrmannN.BowlesS.The use of non-prescription sleep products in the elderly.Int J Geriatr Psychiatry.19991485185710521884
   PubMed Web of Science ®Google Scholar
• McRaeS.Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng.Can Med Assoc J.19961552932958705908
   PubMed Web of Science ®Google Scholar
• MatthewsHB.LucierGW.FisherKD.Medicinal herbs in the United States: research needs.Environ Health Perspect.199910777377810504141
   PubMed Web of Science ®Google Scholar
• LantzMS.BuchalterE.GiambancoV.St. John's wort and antidepressant drug interactions in the elderly.J Geriatr Psychiatry Neurol.19991271010447148
   PubMed Web of Science ®Google Scholar
• AtkinPA.VeitchPC.VeitchEM.OgleSJ.The epidemiology of serious adverse drug reactions among the elderly.Drugs Aging.19991414115210084366
   PubMed Web of Science ®Google Scholar
• BeythRJ.ShorrRl.Epidemiology of adverse drug reactions in the elderly by drug class.Drugs Aging.19991423123910220106
   PubMed Web of Science ®Google Scholar
• UppalR.JhajR.MalhotraS.Adverse drug reactions among inpatients in a north Indian referral hospital.Natl Med J India.200013161810743370
   PubMed Web of Science ®Google Scholar
• Interventions to reduce drug-related reactions among communityresident elderly Medicare and Medicaid patients. Washington, DC: United States Department of Health and Human Services. May 1993. www.hhs.gov/aspe/pic/7/pic4477.txt. Accessed August 6, 2001.
   Google Scholar
• ZuccalaG.OnderG.CarboninP.BernabeiR.Adverse drug reactions in the elderly: need for dedicated databases.Arch Intern Med.20001601700170110847266
   PubMedGoogle Scholar
• MannesseCK.DerkxFH.de RidderMA.Man in't VeldAJ.van der CammenTJ.Contribution of adverse drug reactions to hospital admission of older patients.Age Ageing.200029353910690693
   PubMed Web of Science ®Google Scholar
• WoodcockJ.Testimony on medical errors: understanding adverse drug events. Washington, DC: Department of Health and Hman Services. February 2000. www.hhs.gov/asl/testify/t000201a.html. Accessed August 6, 2001.
   Google Scholar
• van EijkME.BahriP.DekkerG.et al.Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects.J Clin Epidemiol.20005364565110880785
   PubMed Web of Science ®Google Scholar
• LarsonEB.KukullWA.BuchnerD.ReiflerBV.Adverse drug reactions associated with global cognitive impairment in elderly persons.Ann Intern Med.19871071691732886086
   PubMed Web of Science ®Google Scholar
• MooreAR.O'KeeffeST.Drug-induced cognitive impairment in the elderly.Drugs Aging.199915152810459729
   PubMed Web of Science ®Google Scholar
• SleeperR.BondCA.Rojas-FernandezC.Psychotropic drugs and falls: new evidence pertaining to serotonin reuptake inhibitors.Pharmacotherapy.20002030831710730686
   PubMed Web of Science ®Google Scholar
• HanrattyCG.McGlincheyP.JohnstonGD.PassmoreAP.Differential pharmacokinetics of digoxin in elderly patients.Drugs Aging.20001735336211190416
   PubMed Web of Science ®Google Scholar
• PedigoNW.Jr.Neurotransmitter receptor plasticity in aging.Life Sci.199455198519917997057
   PubMed Web of Science ®Google Scholar
• HatanpaaK.IsaacsKR.ShiraoT.BradyDR.RapoportSI.Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease.J Neuropathol Exp Neurol.19995863764310374754
   PubMed Web of Science ®Google Scholar
• FowlerCJ.CowburnRF.JosephJA.Alzheimer's, ageing and amyloid: an absurd allegory?.Gerontology.1997431321428996835
   PubMed Web of Science ®Google Scholar
• von MoltkeLL.AbernethyDR.GreenblattDJ.Kinetics and dynamics of psychotropic drugs in the elderly. In: Salzman C, ed.Clinical Geriatric Psychopharmacology Baltimore, Md: Williams & Wilkins19987093
   Google Scholar
• von MoltkeLL.GreenblattDJ.HarmatzJS.ShaderRl.Psychotropic drug metabolism in old age: principles and problems of assessment. In: Bloom FE, Kupfer DJ, eds.Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press199514611469
   Google Scholar
• von MoltkeLL.GreenblattDJ.ShaderRl.Clinical pharmacokinetics of antidepressants in the elderly: therapeutic implications.Clin Pharmacokinet.1993241411608471078
   PubMed Web of Science ®Google Scholar
• von MoltkeLL.GreenblattDJ.Pharmacokinetics of psychotropic drugs in the elderly.Ann Rev Gerontol Geriatr.1999195371
   Google Scholar
• HämmerleinA.DerendorfH.LowenthalDT.Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications.Clin Pharmacokinet.19983549649673834
   PubMed Web of Science ®Google Scholar
• VestalRE.Aging and pharmacology.Cancer.199780130213109317183
   PubMed Web of Science ®Google Scholar
• DurnasC.LoiCM.CusackBJ.Hepatic drug metabolism and aging.Clin Pharmacokinet.1990193593892268986
   PubMed Web of Science ®Google Scholar
• MontamatSC.CusackBJ.VestalRE.Management of drug therapy in the elderly.N Engl J Med.19893213033092664519
   PubMed Web of Science ®Google Scholar
• PollockBG.Psychotropic drugs and the aging patient.Geriatrics.199853(suppl 1)S20S249745631
   PubMed Web of Science ®Google Scholar
• GreenblattDJ.HarmatzJS.ShaderRl.Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations (Part I).Clin Pharmacokinet1991211651771684924
   PubMed Web of Science ®Google Scholar
• GreenblattDJ.HarmatzJS.ShaderRl.Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations (Part II).Clin Pharmacokinet.1991212622731684744
   PubMed Web of Science ®Google Scholar
• GreenblattDJ.SellersEM.ShaderRl.Drug disposition in old age.N Engl J Med.1982306108110887040951
   PubMed Web of Science ®Google Scholar
• SellersEM.FleckerRC.RomachMK.Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.Drug Metab Rev.1983142252506341026
   PubMed Web of Science ®Google Scholar
• FoyA.O'ConnellD.HenryD.KellyJ.CockingS.HallidayJ.Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients.J Gerontol A Biol Sci Med Sci.199550M99M1067874596
   PubMed Web of Science ®Google Scholar
• PullenR.Psychopharmaka und Fahrtauglichkeit bel alteren Patienten.Versicherungsmedizin.199951717410420837
   PubMedGoogle Scholar
• American Psychiatric Asssociation.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association Press1994
   Google Scholar
• JacobsonS.ShaderRl.Delirium and dementia. In: Shader Rl, ed.Manual of Psychiatric Therapeutics. 3rd ed. Boston, Mass: Little Brown and Co2001
   Google Scholar
• MorganK.Hypnotic drugs, psychomotor performance and aging.J Sleep Res.1994311510607103
   PubMed Web of Science ®Google Scholar
• GreenblattDJ.HarmatzJS.ShapiroL.EngelhardtN.GouthroTA.ShaderRl.Sensitivity to triazolam in the elderly.N Engl J Med.1991324169116982034245
   PubMed Web of Science ®Google Scholar
• BertzRJ.KrobothPD.KrobothFJ.et al.Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.J Pharmacol Exp Ther1997281131713299190868
   PubMed Web of Science ®Google Scholar
• KatzIR.SandsLP.BilkerW.DiFilippoS.BoyceA.D'AngeloK.Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.J Am Geriatr Soc.1998468139434659
   PubMed Web of Science ®Google Scholar
• ThapaPB.GideonP.FoughtRL.RayWA.Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents.Am J Epidemiol.19951422022117598120
   PubMed Web of Science ®Google Scholar
• MendelsonWB.The use of sedative/hypnotic medication and its correlation with falling down in the hospital.Sleep.1996196987019122555
   PubMed Web of Science ®Google Scholar
• CampbellAJ.Drug treatment as a cause of falls in old age: a review of the offending agents.Drugs Aging.199112893021794021
   PubMedGoogle Scholar
• GummingRG.Epidemiology of medication-related falls and fractures in the elderly.Drugs Aging.19981243539467686
   PubMed Web of Science ®Google Scholar
• KripkeDF.KlauberMR.WingardDL.FellRL.AssmusJD.GarfinkelL.Mortality hazard associated with prescription hypnotics.Biol Psychiatry.1998436876939583003
   PubMed Web of Science ®Google Scholar
• SimsRV.OwsleyC.AllmanRM.BallK.SmootTM.A preliminary assessment of the medical and functional factors associated with vehicle crashes by older adults.J Am Geriatr Soc.1998465565619588367
   PubMed Web of Science ®Google Scholar
• LeveilleSG.BuchnerDM.KoepsellTD.McCloskeyLW.WolfME.WagnerEH.Psychoactive medications and injurious motor vehicle collisions involving older drivers.Epidemiology.199455915987841240
   PubMed Web of Science ®Google Scholar
• McGwinG.SimsRV.PulleyL.RosemanJM.Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study.Am J Epidemiol.200015242443110981455
   PubMed Web of Science ®Google Scholar
• “Benzodiazepine/Driving” Collaborative Group. Are benzodiazepines a risk factor for road accidents?.Drug Alcohol Depend.19933319228103737
   PubMed Web of Science ®Google Scholar
• SunderlandT.Neurotransmission in the aging central nervous system. In: Salzman C, ed.Clinical Geriatric Psychopharmacology. Baltimore, Md: Williams & Wilkins19985169
   Google Scholar
• GreenblattDJ.DivollMK.AbernethyDR.OchsHR.HarmatzJS.ShaderRl.Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.Pharmacology.1989383273342762375
   PubMed Web of Science ®Google Scholar
• von MoltkeLL.GreenblattDJ.Drug transporters in psychopharmacology-are they important?.J Clin Psychopharmacol.20002029129410831014
   PubMed Web of Science ®Google Scholar
• SchinkelAH.WagenaarE.van DeemterL.MolCA.BorstP.Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.J Clin Invest.199596169817057560060
   PubMed Web of Science ®Google Scholar
• ParikhC.Antidepressants in the elderly: challenges for study design and their interpretation.Br J Clin Pharmacol.20004953954710848717
   PubMed Web of Science ®Google Scholar
• Physicians Desk. Reference. 55th ed. Ordell, NJ: Medical Economics Company2001
   Google Scholar
• PattenSB.LoveEJ.Drug-induced depression.Psychother Psychosom.19976663739097332
   PubMed Web of Science ®Google Scholar
• KaplanGB.GreenblattDJ.EhrenbergBL.GoddardJE.HarmatzJS.ShaderRl.Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects.J Clin Pharmacol.19983814219597554
   PubMed Web of Science ®Google Scholar
• GreenblattDJ.von MoltkeLL.Sedative-hypnotic, anxiolytic agents. In: Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, eds.Metabolic Drug Interactions. Philadelphia, Pa: Lippincott, Williams and Wilkins2000259270
   Google Scholar
• GreenblattDJ.WrightCE.von MoltkeLL.et al.Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.Clin Pharmacol Ther.1998642372479757147
   PubMed Web of Science ®Google Scholar
• MartinezR.MolchanSE.LawlorBA.et al.Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humans.Biol Psychiatry.19974150578988795
   PubMed Web of Science ®Google Scholar
• NebesRD.PollockBG.MulsantBH.ButtersMA.ZmudaMD.ReynoldsCF.Cognitive effects of paroxetine in older depressed patients.J Clin Psychiatry.199960(suppl 20)262910513855
   PubMed Web of Science ®Google Scholar
• LittrellRA.HayesLR.StillnerV.Carisoprodol (Soma): a new and cautious perspective on an old agent.South Med J.1993867537568322081
   PubMed Web of Science ®Google Scholar
• MontastrucJL.ChaumerliacC.DesboeufK.et al.Adverse drug reactions to selegiline: a review of the French pharmacovigilance database.Clin Neuropharmacol.20002327127511154095
   PubMed Web of Science ®Google Scholar
• YoungBK.CamicioliR.GanziniL.Neuropsychiatrie adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.Drugs Aging.1997103673839143857
   PubMed Web of Science ®Google Scholar
• FactorSA.MolhoES.PodskalnyGD.BrownD.Parkinson's disease: druginduced psychiatric states.Adv Neurol.1995651151387872135
   PubMedGoogle Scholar
• GuayDR.Amantadine, rimantadine prophylaxis of influenza A in nursing homes. Atolerability perspective.Drugs Aging.199458197919641
   PubMed Web of Science ®Google Scholar
• PostmaJU.Van TilburgW.Visual hallucinations and delirium during treatment with amantadine (Symmetrel).J Am Geriatr Soc.197523212215123540
   PubMed Web of Science ®Google Scholar
• WongICK.TavernorSJ.TavernorRME.Psychiatric adverse effects of anticonvulsant drugs: incidence and therapeutic implications.CNS Drugs.19978492509
   Web of Science ®Google Scholar
• Families USA. Still rising: drug price increases for seniors 1999-2000. Washington DC: Families USA Foundation. Publication 00-103. April 2000. www.familiesusa.org/media/pdf/pdrug.pdf. Accessed August 6, 2001.
   Google Scholar
• MiuraT.KojimaR.SugiuraY.MizutaniM.TakatsuF.SuzukiY.Effect of aging on the incidence of digoxin toxicity.Ann Pharmacother.20003442743210772425
   PubMed Web of Science ®Google Scholar
• MunroeWP.RindoneJP.KershnerRM.Systemic side effects associated with the ophthalmic administration of timolol.Drug Intell Clin Pharm.19851985893882377
   PubMedGoogle Scholar
• RogersTK.BowmanCE.Cognitive impairment associated with betablockade in the elderly.Postgrad Med J.199066105010522084652
   PubMed Web of Science ®Google Scholar
• TurnerWM.Lidocaine and psychotic reactions.Ann Intern Med.1982971491507092001
   PubMed Web of Science ®Google Scholar
• SternbachH.StateR.Antibiotics: neuropsychiatrie effects and psychotropic interactions.Harv Rev Psychiatry.199752142269427014
   PubMed Web of Science ®Google Scholar
• AndrejakM.SchmitJL.TondriauxA.HaryL.DebailleuxS.MooreN.Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin [In French].Thérapie.199247415418
   PubMed Web of Science ®Google Scholar
• BallP.TillotsonG.Tolerability of fluoroquinolone antibiotics. Past, present and future.Drug Safety.1995133433588652079
   PubMed Web of Science ®Google Scholar
• SchliamserSE.CarsO.NorrbySR.Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis.J Antimicrob Chemother.1991274054251856121
   PubMed Web of Science ®Google Scholar
• NorrbySR.Neurotoxicity of carbapenem antibacterials.Drug Saf.19961587908884160
   PubMed Web of Science ®Google Scholar
• VarneyNR.AlexanderB.MaclndoeJH.Reversible steroid dementia in patients without steroid psychosis.Am J Psychiatry.19841413693726703100
   PubMed Web of Science ®Google Scholar
• LewisDA.SmithRE.Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature.J Affect Disord.198353193326319464
   PubMed Web of Science ®Google Scholar
• MaesM.CapuronL.RavaudA.et al.Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.Neuropsychopharmacology.20012413014011120395
   PubMed Web of Science ®Google Scholar
• MalaguarneraM.Di FazioI.RestucciaS.PistoneG.FerlitoL.RampelloL.Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha.Neuropsychobiology19983793979566274
   PubMed Web of Science ®Google Scholar
• FormanWB.Opiold analgesic drugs in the elderly.Clin Geriatr Med.1996124895008853941
   PubMed Web of Science ®Google Scholar
• EisendrathSJ.GoldmanB.DouglasJ.DimatteoL.Van DykeC.Meperidine-induced delirium.Am J Psychiatry.1987144106210653605428
   PubMed Web of Science ®Google Scholar
• RomachMK.SprouleBA.SellersEM.SorrierG.BustoUE.Long-term codeine use is associated with depressive symptoms.J Clin Psychopharmacol.19991937337610440467
   PubMed Web of Science ®Google Scholar
• LebowitzBD.PearsonJL.SchneiderLS.et al.Diagnosis and treatment of depression in late life.JAMA.1997278118611909326481
   PubMed Web of Science ®Google Scholar